Summit Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-57,628
Closed -$5.03M 490
2024
Q1
$5.03M Sell
57,628
-931
-2% -$81.3K 0.3% 45
2023
Q4
$5.65M Sell
58,559
-5,169
-8% -$498K 0.37% 36
2023
Q3
$5.64M Buy
63,728
+1,369
+2% +$121K 0.42% 32
2023
Q2
$5.41M Buy
+62,359
New +$5.41M 0.39% 31